A study of 781 people enrolled in a colorectal cancer prevention clinical trial finds that elevated levels of red blood cell folate is associated with the deactivation of two anti-cancer genes known to be silenced in colorectal cancer.
A study of 781 people enrolled in a colorectal cancer prevention clinical trial finds that elevated levels of red blood cell folate is associated with the deactivation of two anti-cancer genes known to be silenced in colorectal cancer.